• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠胰神经内分泌肿瘤中的表观遗传调控

Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors.

作者信息

Crabtree Judy S

机构信息

Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.

出版信息

Front Oncol. 2022 Jun 7;12:901435. doi: 10.3389/fonc.2022.901435. eCollection 2022.

DOI:10.3389/fonc.2022.901435
PMID:35747820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9209739/
Abstract

Gastroenteropancreatic neuroendocrine neoplasms are a rare, diverse group of neuroendocrine tumors that form in the pancreatic and gastrointestinal tract, and often present with side effects due to hormone hypersecretion. The pathogenesis of these tumors is known to be linked to several genetic disorders, but sporadic tumors occur due to dysregulation of additional genes that regulate proliferation and metastasis, but also the epigenome. Epigenetic regulation in these tumors includes DNA methylation, chromatin remodeling and regulation by noncoding RNAs. Several large studies demonstrate the identification of epigenetic signatures that may serve as biomarkers, and others identify innovative, epigenetics-based targets that utilize both pharmacological and theranostic approaches towards the development of new treatment approaches.

摘要

胃肠胰神经内分泌肿瘤是一组罕见且多样的神经内分泌肿瘤,形成于胰腺和胃肠道,常因激素分泌过多而出现副作用。已知这些肿瘤的发病机制与多种基因紊乱有关,但散发性肿瘤是由于调控增殖、转移以及表观基因组的其他基因失调所致。这些肿瘤中的表观遗传调控包括DNA甲基化、染色质重塑以及非编码RNA的调控。多项大型研究表明,已鉴定出可能作为生物标志物的表观遗传特征,其他研究则确定了基于表观遗传学的创新靶点,这些靶点利用药理学和诊疗方法来开发新的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/9209739/1ce21dc5993c/fonc-12-901435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/9209739/61aba11ebddf/fonc-12-901435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/9209739/1ce21dc5993c/fonc-12-901435-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/9209739/61aba11ebddf/fonc-12-901435-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b452/9209739/1ce21dc5993c/fonc-12-901435-g002.jpg

相似文献

1
Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤中的表观遗传调控
Front Oncol. 2022 Jun 7;12:901435. doi: 10.3389/fonc.2022.901435. eCollection 2022.
2
Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.胃肠胰神经内分泌肿瘤的表观遗传学:临床病理视角
World J Gastrointest Oncol. 2017 Sep 15;9(9):341-353. doi: 10.4251/wjgo.v9.i9.341.
3
Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine Neoplasias.探索胃肠胰神经内分泌肿瘤中的表观基因组
Cancers (Basel). 2021 Aug 20;13(16):4181. doi: 10.3390/cancers13164181.
4
Neuroendocrine tumours: cracking the epigenetic code.神经内分泌肿瘤:破解表观遗传密码。
Endocr Relat Cancer. 2013 May 20;20(3):R65-82. doi: 10.1530/ERC-12-0338. Print 2013 Jun.
5
DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.DNA 甲基转移酶 1、3a 和 3b 的过表达与胃肠胰神经内分泌肿瘤的临床意义。
Hum Pathol. 2010 Aug;41(8):1069-78. doi: 10.1016/j.humpath.2010.01.011. Epub 2010 Apr 8.
6
Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.胃肠胰神经内分泌肿瘤的遗传学和表观遗传学。
Endocr Rev. 2019 Apr 1;40(2):506-536. doi: 10.1210/er.2018-00160.
7
Genetic and epigenetic alterations in pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤中的遗传和表观遗传改变。
J Gastrointest Oncol. 2020 Jun;11(3):567-577. doi: 10.21037/jgo.2020.03.11.
8
Epigenetic regulation in human melanoma: past and future.人类黑色素瘤中的表观遗传调控:过去与未来
Epigenetics. 2015;10(2):103-21. doi: 10.1080/15592294.2014.1003746.
9
Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.胃-肠-胰神经内分泌肿瘤的分子病理学。
Endocr Pathol. 2021 Mar;32(1):169-191. doi: 10.1007/s12022-021-09662-5. Epub 2021 Jan 18.
10
Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.非功能性胰腺神经内分泌肿瘤起源细胞的表观遗传特征的临床意义。
J Pathol. 2022 Feb;256(2):143-148. doi: 10.1002/path.5834. Epub 2021 Dec 18.

引用本文的文献

1
FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs.粘着斑激酶(FAK)抑制可破坏胃肠道神经内分泌肿瘤(GI-NETs)的肿瘤生长、细胞凋亡及转录调控。
Endocr Oncol. 2025 Aug 14;5(1):e250052. doi: 10.1530/EO-25-0052. eCollection 2025 Jan.
2
Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine Tumors.表观遗传修饰作为甲状腺、胰腺和肺神经内分泌肿瘤诊断、预后及治疗靶点的新型生物标志物
J Clin Med. 2025 Apr 11;14(8):2622. doi: 10.3390/jcm14082622.
3
Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors.

本文引用的文献

1
miRNAs in Cancer (Review of Literature).miRNAs 在癌症中的作用(文献综述)。
Int J Mol Sci. 2022 Mar 3;23(5):2805. doi: 10.3390/ijms23052805.
2
Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification.胰腺神经内分泌肿瘤:基于世卫组织分类的遗传性肿瘤综合征和散发性肿瘤中基因组改变的最新信息。
Crit Rev Oncol Hematol. 2022 Apr;172:103648. doi: 10.1016/j.critrevonc.2022.103648. Epub 2022 Mar 4.
3
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.
免疫疗法在小肠神经内分泌肿瘤治疗中的现状。
Curr Oncol Rep. 2024 Nov;26(11):1530-1542. doi: 10.1007/s11912-024-01610-w. Epub 2024 Oct 28.
4
Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation.胰腺神经内分泌肿瘤:信号通路与表观遗传调控
Int J Mol Sci. 2024 Jan 22;25(2):1331. doi: 10.3390/ijms25021331.
5
Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease.神经内分泌肿瘤:基因组学与分子生物标志物,重点关注转移性疾病
Cancers (Basel). 2023 Apr 12;15(8):2249. doi: 10.3390/cancers15082249.
6
An Insight on Functioning Pancreatic Neuroendocrine Neoplasms.关于功能性胰腺神经内分泌肿瘤的见解
Biomedicines. 2023 Jan 21;11(2):303. doi: 10.3390/biomedicines11020303.
7
Insights into Epigenetic Changes Related to Genetic Variants and Cells-of-Origin of Pancreatic Neuroendocrine Tumors: An Algorithm for Practical Workup.胰腺神经内分泌肿瘤相关遗传变异和起源细胞的表观遗传变化洞察:实用检查算法
Cancers (Basel). 2022 Sep 13;14(18):4444. doi: 10.3390/cancers14184444.
DNA 甲基化揭示了胰腺神经内分泌癌和胰腺神经内分泌肿瘤的不同起源细胞。
Genome Med. 2022 Mar 1;14(1):24. doi: 10.1186/s13073-022-01018-w.
4
Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.当前和新的挑战在管理胰腺神经内分泌肿瘤: miRNA 为基础的方法的作用作为新的可靠的生物标志物。
Int J Mol Sci. 2022 Jan 20;23(3):1109. doi: 10.3390/ijms23031109.
5
RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1.RASSF1A 通过 SNURF/RNF4 介导的 HES1 泛素化破坏 NOTCH 信号通路。
EMBO Rep. 2022 Feb 3;23(2):e51287. doi: 10.15252/embr.202051287. Epub 2021 Dec 13.
6
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System.胃肠道神经内分泌癌的全面基因组分析。
Cancer Discov. 2022 Mar 1;12(3):692-711. doi: 10.1158/2159-8290.CD-21-0669.
7
EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine.EZH2 为小肠神经内分泌肿瘤提供了一个治疗靶点。
Sci Rep. 2021 Nov 23;11(1):22733. doi: 10.1038/s41598-021-02181-7.
8
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.基于合成水凝胶的前列腺癌类器官中的细胞外基质调节对 EZH2 和 DRD2 抑制剂的治疗反应。
Adv Mater. 2022 Jan;34(2):e2100096. doi: 10.1002/adma.202100096. Epub 2021 Nov 14.
9
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).EZH2抑制作为胰腺神经内分泌肿瘤(PanNENs)的新表观遗传学治疗选择。
Cancers (Basel). 2021 Oct 7;13(19):5014. doi: 10.3390/cancers13195014.
10
Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST ) in pituitary and pancreatic neuroendocrine tumors.生长抑素受体亚型 5(SST)在垂体和胰腺神经内分泌肿瘤中的表观遗传和转录后调控。
Mol Oncol. 2022 Feb;16(3):764-779. doi: 10.1002/1878-0261.13107. Epub 2021 Oct 26.